Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2008
11/20/2008US20080286760 Means and Methods for the Determination of Camp In Vitro and In Vivo
11/20/2008US20080286415 Proteases
11/20/2008US20080286311 providing a wild-type protein allergen, splicing it into two parts that have a reduced allergenic activity or lacking allergenic activity and rejoining the two fragments in inverse orientation; allergy immunotherapy; low risk for anaphylactic shock; preparation of antiallergens
11/20/2008US20080286309 Portion of SpaA protein is deleted for protection from Erysipelothrix rhusiopathiae infection; genetic engineering; Porcine erysipelas; high purity
11/20/2008US20080286297 Chimeric Carrier Molecules for the Production of Mucosal Vaccines
11/20/2008US20080286295 Use of recombinant antigens to determine the immune status of an animal
11/20/2008US20080286290 Anti-Cd14 Antibody Fusion Protein
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/20/2008US20080286284 Compositions of PSMA antibodies
11/20/2008US20080286283 Treatment of cancer with antibodies to costimulating polypeptide of T cells
11/20/2008US20080286277 Monoclonal antibody comprising specificity determining residues for targeting tumor cells for destruction
11/20/2008US20080286276 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
11/20/2008US20080286275 Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication
11/20/2008US20080286198 Novel anti-IGF-IR antibodies and uses thereof
11/20/2008CA2687082A1 Improved feed media
11/20/2008CA2686554A1 Optimization of colicin production
11/20/2008CA2685859A1 Human bnp immunospecific antibodies
11/20/2008CA2670014A1 Production of anti-microbial peptides
11/20/2008CA2668208A1 Hybrid immunoglobulins with moving parts
11/19/2008EP1992698A1 METHOD FOR SYNTHESIS OF SUPPRESSOR tRNA, DNA CONSTRUCT, AND PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE DNA CONSTRUCT
11/19/2008EP1992697A1 Production of TNFR-Fc
11/19/2008EP1992695A2 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
11/19/2008EP1992686A1 OXA1P enhanced protein secretion
11/19/2008EP1992644A1 Antibodies against CCR4 and its fragments
11/19/2008EP1992643A2 Compositions and methods for the diagnosis and treatment of tumor
11/19/2008EP1992640A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1991680A2 System for the expression of orthogonal translation components in eubacterial host cells
11/19/2008EP1991273A2 Labeling and detection of post translationally modified proteins
11/19/2008EP1991246A2 Treatment of development-related disorders
11/19/2008EP1791961A4 Protein production method utilizing yebf
11/19/2008EP1692156A4 Self-assembling split-fluorescent protein systems
11/19/2008EP1495146B1 Antibody libraries
11/19/2008EP1373510B1 Mutant allergens
11/19/2008EP1358213B1 Humanized antibodies that recognize beta amyloid peptide
11/19/2008EP1330475B1 Neuromedin u delta polypeptides
11/19/2008EP1294910B1 Protein glycosylation modification in pichia pastoris
11/19/2008EP1141371B1 Methods for producing polypeptides in aspergillus mutant cells
11/19/2008EP1132400B1 Novel protein, gene encoding the same and method of utilization thereof
11/19/2008EP0981630B1 Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
11/19/2008EP0802921B1 Human pak65
11/19/2008EP0745122B1 Galanin receptor, nucleic acids, transformed cells and uses thereof
11/19/2008CN101309932A Novel mucin glycoprotein and use thereof
11/19/2008CN101307348A Method for preparing undenatured collagen from fish scale of fresh water fish
11/19/2008CN101307347A Method for extracting brain strengthening bioactive carnosine from genitalia tissue of farming animals
11/19/2008CN101307346A Method for extracting brain strengthening bioactive peptide from brain tissue of farming animals
11/19/2008CN101307333A Process for the poduction of biogas and further fermentation products from a hydrolysate
11/19/2008CN101307312A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
11/19/2008CN101306019A Hyper-concentrated placenta nano viable cell freeze-drying capsules and its preparation method
11/19/2008CN101306017A Hyper-concentrated placenta lipopolysaccharide freeze-drying capsules and its preparation method
11/19/2008CN100434530C Proteinic small peptide of Placenta and preparation method thereof
11/19/2008CN100434529C III type proteinic small peptide and preparation technique thereof
11/19/2008CN100434528C Simplified method for extracting a great lot phycocyanin
11/19/2008CN100434522C Production method of recombination human growth hormone
11/18/2008US7452980 Compositions and methods for the diagnosis and treatment of immune disorders
11/18/2008US7452979 Cancerous disease modifying antibodies
11/18/2008US7452978 Cancerous disease modifying antibodies
11/18/2008US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452975 Induction of chrondrocyte proliferation/differentiation; antitumor agents; antiinflammatory agents; antiproliferative agents; anticarcinogenic agents; antisense agents; cancer diagnosis
11/18/2008US7452970 G-protein coupled receptors for identifying modulators for prevention and treatment of cardiovascular, urogenital and hypertensive disorders
11/18/2008US7452969 Neurotrophic factor protein and uses thereof
11/18/2008US7452968 proteins that modulate the growth, differentiation, trafficking and physiology of mammalian cells, e.g., cells of the hematopoietic system and the neuronal system of mammals
11/18/2008US7452859 Having serine protease inhibitory activity
11/18/2008US7452715 expression of the lipidated form of the peptidoglycan-associated protein (PAL) of gram-negative bacteria is achieved through the use of a plasmid containing a tightly regulated promoter; bacterial host cell transformed, transduced or transfected with the plasmid
11/18/2008US7452707 Cellobiohydrolases-1 (CBH-1) for use as hydrolyzing tool in textile treatment, papermaking, detergents and animal feeds
11/18/2008US7452706 Recombinant bacterial phytases and uses thereof
11/18/2008US7452697 Chromatographic method and system for purifying a botulinum toxin
11/18/2008US7452696 Recombinant plasmid and method for expressing hepatitis B viral antigens and virions in vivo
11/18/2008US7452695 From mammal cells transformed with cytomegalovirus vector using xanthine derivatives (caffeine and/or theobromine) and/or hexamethylene bisacetamide; serum-free
11/18/2008US7452694 Identifying modulators of g-protein coupled receptor associated with taste/flavor transduction; food processing and artificial sweetners
11/18/2008US7452693 Used in antibacterial, immunosuppressant, and antitumor drug making; loading an extender molecule on an acyl carrier protein (ACP) domain
11/18/2008US7452679 Hybridization; phage display; spectroscopy
11/18/2008US7452675 Useful in identifying molecules, that bind TRPM4b (transmembrane channel polypeptides) which modulate TRPM4b ion channel activity, and/or which alter expression of TRPM4b within cells
11/18/2008US7452534 low antigenicity, reduced (or absent) T cell depleting activity, good affinity to human CD4 and enhanced stability (in vivo half-life); chimeric antibodies contain Old World monkey variable sequences and human constant domain sequences
11/18/2008CA2440399C Epitope testing using hla
11/18/2008CA2424624C Expression vectors with modified cole1 origin of replication for control of plasmid copy number
11/18/2008CA2338721C New cofactors for methyltransferases
11/18/2008CA2288234C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2193993C New hil-4 mutant proteins used as antagonists or partial agonists of human interleukin 4
11/18/2008CA2172376C Antibodies to cd40
11/18/2008CA2157975C Recombinant mersacidin and a method for production
11/18/2008CA2136230C Clostridium perfringens vaccines
11/18/2008CA2095421C Novel amyloid precursor proteins and methods of using same
11/18/2008CA1341585C Recombinant retroviruses
11/13/2008WO2008137382A1 Anti-tissue factor antibodies and compositions with enhanced effector function
11/13/2008WO2008136398A1 Cell culture method using amino acid-enriched medium
11/13/2008WO2008136345A1 Polypeptide capable of improving tolerance to iron deficiency in plant, and use thereof
11/13/2008WO2008136253A1 Viral vector and use thereof
11/13/2008WO2008135498A2 Prevention of protein degradation in mammalian cell cultures
11/13/2008WO2008134879A1 Il-12 immunotherapy for cancer
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008115596A3 Over expression of foldases and chaperones improves protein production
11/13/2008WO2008089132A3 Genetic selection for protein folding and solubility in the bacterial periplasm
11/13/2008WO2008070727A3 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
11/13/2008WO2008048545A3 Molecules with reduced half-lives, compositions and uses thereof
11/13/2008WO2008030968A3 Fusion peptide therapeutic compositions
11/13/2008WO2008027800A3 Method for enhancing the efficacy of antigen specific tumor immunotherapy
11/13/2008WO2008021976A3 Anti-interferon alpha monoclonal antibodies and methods for use